TGFB1 and type 2 diabetes mellitus: Due to the low number of isolated circulating monocytes from patients we employed an in vitro system of high glucose to ‘mimic’ diabetic conditions (high glucose), in order to investigate the molecular mechanisms underlying the enhanced TGF‐β‐induced monocyte responses seen in T2DM.